KaloBios Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
KaloBios Pharmaceuticals, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HUMANEERED. The owner is based in South San Francisco, CA.
260 East Grand Avenue
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
KaloBios Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does KaloBios Pharmaceuticals, Inc. have?
KaloBios Pharmaceuticals, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does KaloBios Pharmaceuticals, Inc. file in?
KaloBios Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are KaloBios Pharmaceuticals, Inc.'s most well-known trademarks?
KaloBios Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as HUMANEERED. These are among 1 currently registered trademark in the portfolio.
What is KaloBios Pharmaceuticals, Inc.'s trademark registration success rate?
KaloBios Pharmaceuticals, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.